Entry Detail



General Information

Database ID:exR0080591
RNA Name:RPL27A
RNA Type:mRNA
Chromosome:chr11
Starnd:+
Coordinate:
Start Site(bp):8682788End Site(bp):8714759
External Links:ENSG00000166441



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC245033.1
chr15
82536788
82573194
-
ABHD6
chr3
58237532
58295693
+
ADGRE5
chr19
14380501
14408725
+
ABCG2
chr4
88090150
88231628
-
AL136454.1
chr1
192716132
192716653
+
ABHD10
chr3
111979010
111993368
+
ACTR3B
chr7
152759749
152855378
+
ACTN3
chr11
66546395
66563334
+
ADCK2
chr7
140672945
140696261
+
AGPAT3
chr21
43865223
43987592
+
ALDOA
chr16
30064164
30070457
+
AKR1A1
chr1
45550543
45570049
+
AHSA1
chr14
77457870
77469472
+
AGGF1
chr5
77029251
77065234
+
ACOT7
chr1
6264269
6394391
-
AC068580.4
chr11
1734821
1763954
-
AGBL2
chr11
47659591
47715389
-
ADSL
chr22
40346500
40390463
+
AKR1B1
chr7
134442356
134459284
-
AC007192.1
chr19
18153158
18178117
+
AL022238.4
chr22
40346529
40410054
+
ADGRL2
chr1
81306160
81992436
+
ABCC4
chr13
95019835
95301475
-
ACD
chr16
67657512
67660815
-
AIMP1
chr4
106315544
106349456
+
AGPS
chr2
177392757
177559299
+
AC022826.2
chr8
73688691
73878854
-
AC124312.1
chr15
24955034
25000276
+
ACIN1
chr14
23058564
23095614
-
AGA
chr4
177430774
177442437
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-3064-5p
chr17
64500817
64500837
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004687.1
chr17
58330884
58332508
-
AC016876.2
chr17
7581964
7584086
-
AC020978.5
chr16
68225969
68229145
-
AC023509.1
chr12
53441741
53467528
+
AC068768.1
chr12
123262060
123262402
+
AC074183.1
chr7
84939349
84940245
-
AC090114.2
chr7
128524016
128531069
-
AC090825.1
chr15
99805793
99916818
+
AC106864.1
chr4
112693047
112706810
-
AC132217.1
chr11
2129121
2129964
-
AC245014.3
chr1
145281116
145281462
+
AC245033.4
chr15
82533175
82540008
-
AL021707.2
chr22
38667585
38681847
-
AL022311.1
chr22
37876148
37895563
+
AL031595.3
chr22
44139365
44153626
+
AL035458.2
chr20
34234840
34281173
-
AL050341.2
chr1
40256427
40257967
-
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA